A total of 589 porcine bioprostheses were implanted in 509 patients from January, 1976,
through December, 1983. Of the valves implanted, 390 were Hancock and 199 were …

The porcine bioprosthetic heart valve has been commercially available since 1970 and has
been the prosthetic heart valve of choice in our institution since 1971. Since that time 817 …

Clinical results with porcine bioprostheses were reviewed for 990 patients who underwent
heart valve replacement from January, 1974, to December, 1980. Eight hundred and …

Valve-related morbidity and mortality after heart valve replacement with the Hancock I
porcine bioprosthesis has been retrospectively analyzed. From June 1974 through …

Abstract From 1976 to 1988, 1,593 patients underwent valve replacement with a porcine
(878 patients) or a pericardial bioprosthesis (715 patients). There were 701 aortic, 678 …

The Carpentier‐Edwards standard porcine bioprosthesis was implanted in 1,195 patients in
1,213 operative procedures between 1975 and 1987, with the majority of implants …

Porcine bioprostheses provide an excellent alternative to mechanical prostheses for heart
valve replacement in patients unable to comply with systemic anticoagulation and in the …

The Hancock porcine valve was the first commercially available biologic heart valve and has
been in continuous use at the Brigham and Women's Hospital since January 1972. Through …

Carpentier-Edwards bioprostheses were implanted in 605 patients, 509 of whom had a
single valve replacement, and 96 of whom had a multiple valve replacement. There were 54 …

Long-term evaluation of patients undergoing combined mitral and aortic valve replacement
(MVR+ AVR) with a porcine bioprosthesis provides the opportunity for a direct comparison of …